Abrdn Life Sciences Investors (HQL)

HQL Revenue

In the fiscal year ending September 30, 2025, Abrdn Life Sciences Investors had annual revenue of $1.94M, down -51.30%. Abrdn Life Sciences Investors had revenue of $576.56K in the half year ending September 30, 2025, a decrease of -70.12%.

• Revenue (ttm): $1.94M
• Revenue Growth: -51.30%
• P/S Ratio: 263.40
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 510.58M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	1.94M	-2.04M	-51.30%
Sep 30, 2024	3.98M	961.03K	31.83%
Sep 30, 2022	3.02M	732.66K	32.05%
Sep 30, 2021	2.29M	-1.11M	-32.59%
Sep 30, 2020	3.39M	951.05K	38.97%